Lataa...
Mammalian target of rapamycin inhibition in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. It is associated with a poor prognosis and has limited treatment options. Sorafenib, a multi-targeted kinase inhibitor, is the only available systemic agent for treatment of HCC that improves overall survi...
Tallennettuna:
| Julkaisussa: | World J Hepatol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243151/ https://ncbi.nlm.nih.gov/pubmed/25429315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v6.i11.776 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|